Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Simultaneous assays of ubiquinol and ubiquinone by HPLC with electrochemical detection. Determination of the pediatric reference intervals for muscle coenzyme Q10
4th International Conference and Exhibition on Analytical & Bioanalytical Techniques
Coenzyme Q
10
(CoQ
10
), a 1, 4-benzoquinone with a 50-carbon isoprenoid side chain, is present in humans in both the reduced
(ubiquinol, CoQ
10
H
2
) and oxidised (ubiquinone, CoQ
10
) forms. CoQ
10
is an essential cofactor in mitochondrial oxidative
phosphorylation, and is necessary for ATP production. Deficiency of CoQ
10
has reported in individuals with neurological disease,
and metabolic disease. A number of methods to measure coenzyme Q
10
in plasma and other biological specimen has been
described (18-21), but no methods for the simultaneous determination of oxidized and reduced forms of CoQ
10
in human skeletal
muscle were reported. Given the increased interest in coenzyme Q
10
and its association with a variety of disease, we developed
a simple and rapid HPLC method with coulometric detection for simultaneous determination of total, reduced and oxidized
CoQ
10
in human skeletal muscle. CoQ
10
levels were determined in skeletal muscle of 148 children, and we established three
level thresholds for total CoQ
10
in muscle. We defined as ?severe deficiency?, CoQ
10
levels falling in the range between 0.82 and
4.88
μ
mol/g tissue, as ?intermediate deficiency?, those ranging between 5.40 and 9.80
μ
mol/g tissue, and as ?mild deficiency?,
the amount of CoQ
10
included between 10.21 and 19.10
μ
mol/g tissue. Early identification of CoQ
10
deficiency has important
implications in children, not only for those with primary CoQ
10
defect, but also for patients with neurodegenerative disorders, in
order to encourage earlier supplementation with this agent also in mild and intermediate deficiency.
Biography
Anna Pastore has completed her Ph.D. at age of 25 years from the Tor Vergata University, and post-doctoral studies form the Children?s Hospital
and Research Institute Bambino Gesł. At present time she is completing the specialization in Clinical Biochemistry from the Tor Vergata University.
She has published more than 75 papers in reputed journals.
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals